DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Total Value
$9.91M
Total Shares
2.41M
Net Share Change
+58.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Miller Value Partners
$9.91M2.41M shares
ADD+58.6K(+2.5%)